Zobrazeno 1 - 7
of 7
pro vyhledávání: '"Francesco del Valle"'
Autor:
Philipp Erben, Darko Gosenca, Martin C. Müller, Jelena Reinhard, Joannah Score, Francesco del Valle, Christoph Walz, Jürgen Mix, Georgia Metzgeroth, Thomas Ernst, Claudia Haferlach, Nicholas C.P. Cross, Andreas Hochhaus, Andreas Reiter
Publikováno v:
Haematologica, Vol 95, Iss 5 (2010)
Background Rapid identification of diverse fusion genes with involvement of PDGFRA or PDGFRB in eosinophilia-associated myeloproliferative neoplasms is essential for adequate clinical management but is complicated by the multitude and heterogeneity o
Externí odkaz:
https://doaj.org/article/3f362a96e85940718ba0f9e8661ef148
Autor:
Richard F. Schlenk, Konstanze Döhner, Michael Kneba, Katharina Götze, Frank Hartmann, Francesco del Valle, Heinz Kirchen, Elisabeth Koller, Jörg T. Fischer, Lars Bullinger, Marianne Habdank, Daniela Späth, Silja Groner, Bernhard Krebs, Sabine Kayser, Andrea Corbacioglu, Andreas Anhalt, Axel Benner, Stefan Fröhling, Hartmut Döhner
Publikováno v:
Haematologica, Vol 94, Iss 1 (2009)
Background In a previous randomized trial, AML HD98B, we showed that administration of all-trans retinoic acid in addition to intensive chemotherapy improved the outcome of older patients with acute myeloid leukemia. The objectives of this study were
Externí odkaz:
https://doaj.org/article/2185ff8a4507470b99c9f55d2382c982
Autor:
Jürgen Mix, Philipp Erben, Francesco del Valle, Jelena Reinhard, Nicholas C.P. Cross, Darko Gosenca, Claudia Haferlach, Georgia Metzgeroth, Thomas Ernst, Andreas Reiter, Joannah Score, Andreas Hochhaus, Martin Müller, Christoph Walz
Publikováno v:
Haematologica. 95:738-744
Background Rapid identification of diverse fusion genes with involvement of PDGFRA or PDGFRB in eosinophilia-associated myeloproliferative neoplasms is essential for adequate clinical management but is complicated by the multitude and heterogeneity o
Autor:
Werner Hunstein, Wolfgang Hiddemann, Walter Fiedler, Günter Schlimok, Rainer Haas, Anthony D. Ho, G. Schulz, Ekhard Thiel, Reinhard Andreesen, J. Frisch, Heide Rückle, Marianne Engelhard, Francesco del Valle
Publikováno v:
Cancer. 66:423-430
Previous study has shown that the combination of mitoxantrone (Novantrone, NO) and Ara-C (AC) (NOAC) was active in refractory non-Hodgkin's lymphoma (NHL) but myelosuppression was dose-limiting. In a pilot study, we investigated the effects of recomb
Autor:
Andrea Corbacioglu, Silja Groner, Francesco del Valle, Richard F. Schlenk, Katharina Götze, Hartmut Döhner, Marianne Habdank, Stefan Fröhling, Daniela Späth, Michael Kneba, Elisabeth Koller, Heinz Kirchen, Konstanze Döhner, Frank Hartmann, J. T. Fischer, Axel Benner
Publikováno v:
Blood. 110:297-297
Background: In a previous randomized trial (AML HD98B) of the AMLSG in elderly (>60 yrs) patients with AML (excluding APL), we could demonstrate that all-trans retinoic acid (ATRA) given as adjunct to intensive chemotherapy significantly improved com
Autor:
Karin Steiner, Julia Loibl, Tanja Kroell, Helga Schmetzer, Francesco del Valle, Nina Hentschel, Hans-Jochen Kolb, Constanze Doehner, Andreas Kremser, Helmut R. Salih, Christoph Schmid, Wolfgang Hiddemann, Christian Schwartz, Stefanie Kufner, Claudia Schweiger
Publikováno v:
Blood. 106:5241-5241
The presentation of leukemic antigens can be improved in AML and MDS by in vitro conversion of leukemic cells in leukemia-derived DC (DCleu), thereby forming a platform for the generation of leukemia-specific cytotoxic lymphocytes (CTL). In prelimina
Autor:
Richard F. Schlenk, Martina Kerz, Arnold Ganser, Hartmut Doehner, Axel Glasmacher, Frank Hartmann, Francesco del Valle, Hans Pralle, Detlef Haase, Katharina Goetze, Matthias Theobald, Hans Salwender, Hans G. Mergenthaler, Stephan Kremers, Elisabeth Koller, Christoph Nerl, Heinz Kirchen, G. Gastl, Axel Matzdorff, Konstanze Doehner
Publikováno v:
Blood. 106:1849-1849
Introduction: Response to first induction therapy is one of the most important prognostic factors in patients with adult myeloid leukemia (AML). Induction of CR or PR is the primary aim in these patients. Methods: Between 1993 and 2005 225 consecutiv